https://www.selleckchem.com/pr....oducts/gsk2126458.ht
lID=12127. Pan African Clinical Trial Registry, PACTR202006669166858, registered on June 19, 2020. https//pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12127. Long non-coding RNA (lncRNA) A2M-AS1 has been indicated to be augmented in breast cancer (BC), with its specific function undetermined. Therefore, this study is designed to investigate the mechanism of lncRNA A2M-AS1 in BC. The expression of A2M-AS1, microRNA (miR)-146b, and MUC19 in BC tissues and cells was measured. Then, the interaction among A2M-AS1, miR-146b, and MUC19 was d
Respect!
Kommentar
Delen
